Genmab A/S (GMAB) Earnings Date, Estimates & Call Transcripts $19.29 -0.47 (-2.38%) Closing price 04:00 PM EasternExtended Trading$19.30 +0.02 (+0.08%) As of 06:27 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Genmab A/S Latest Earnings SummaryUpcoming Q1 Earnings DateMay. 1Before Market OpensEstimatedActual EPS (Feb. 12) $0.57 Beat By $0.29 Consensus EPS (Feb. 12) $0.28 Genmab A/S issued Q4 2024 earnings on February 12, 2025, reporting an EPS of $0.57, which topped the consensus estimate of $0.28 by $0.29. With a trailing EPS of $1.74 and a P/E Ratio of 11.09, Genmab A/S's earnings are expected to grow 22.76% next year, from $1.45 to $1.78 per share. Conference CallGMAB Upcoming EarningsGenmab A/S's next earnings date is estimated for Thursday, May 1, 2025, based off prior year's reporting schedules. Get Genmab A/S Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Genmab A/S and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataGMAB Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.GMAB Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Remove Ads Genmab A/S Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20251$0.18$0.18$0.18Q2 20251$0.39$0.39$0.39Q3 20253$0.43$0.46$0.44Q4 20252$0.44$0.49$0.47FY 20257$1.44$1.52$1.48Q1 20261$0.37$0.37$0.37Q2 20261$0.57$0.57$0.57Q3 20261$0.62$0.62$0.62Q4 20261$0.67$0.67$0.67FY 20264$2.23$2.23$2.23 Remove Ads Genmab A/S Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 5/1/2025(Estimated)-------2/12/2025Q4 2024$0.28$0.57+$0.29$0.85$884.02M-11/6/2024Q3 2024$0.32$0.29 -$0.03$0.29$838.20M$816.10M8/8/2024Q2 2024$0.29$0.22 -$0.07$0.13$734.60M$779.50M5/2/2024Q1 2024$0.16$0.16-$0.03$594.23M$603.30M2/14/2024Q4 2023$0.34$0.36+$0.02$0.58$678.14M$675.29M11/7/2023Q3 2023$0.34$0.47+$0.13$0.47$657.79M$692.80M8/3/2023Q2 2023$0.31$0.30 -$0.01$0.30$618.77M$613.43M5/10/2023Q1 2023$0.09$0.05 -$0.04$0.05$417.27M$411.37M Genmab A/S Earnings - Frequently Asked Questions When is Genmab A/S's earnings date? Genmab A/S has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 1st, 2025 based off last year's report dates. Learn more on GMAB's earnings history. What guidance has Genmab A/S issued on next quarter's earnings? Genmab A/S updated its FY 2025 earnings guidance on Wednesday, February, 12th. The company issued revenue guidance of $3.3 billion-$3.7 billion, compared to the consensus revenue estimate of $3.5 billion. Did Genmab A/S beat their earnings estimates last quarter? In the previous quarter, Genmab A/S (NASDAQ:GMAB) reported $0.57 earnings per share (EPS) to beat the analysts' consensus estimate of $0.28 by $0.29. Learn more on analysts' earnings estimate vs. GMAB's actual earnings. How can I listen to Genmab A/S's earnings conference call? The conference call for Genmab A/S's latest earnings report can be listened to online. Listen to Conference Call How much revenue does Genmab A/S generate each year? Genmab A/S (NASDAQ:GMAB) has a recorded annual revenue of $21.53 billion. How much profit does Genmab A/S generate each year? Genmab A/S (NASDAQ:GMAB) has a recorded net income of $1.14 billion. GMAB has generated $1.74 earnings per share over the last four quarters. What is Genmab A/S's price-to-earnings ratio? Genmab A/S (NASDAQ:GMAB) has a trailing price-to-earnings ratio of 11.09 and a forward price-to-earnings ratio of 13.30. The price/earnings-to-growth ratio is 2.65. What is Genmab A/S's EPS forecast for next year? Genmab A/S's earnings are expected to grow from $1.45 per share to $1.78 per share in the next year, which is a 22.76% increase. More Earnings Resources from MarketBeat Related Companies TAK Earnings Date ARGX Earnings Date ONC Earnings Date BNTX Earnings Date TEVA Earnings Date SMMT Earnings Date ITCI Earnings Date MRNA Earnings Date VTRS Earnings Date RDY Earnings Date Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles After Massive Post Earnings Fall, Does Hope Remain for MongoDB?Semtech Rallies on Earnings Beat—Is There More Upside?These 3 Q1 Earnings Winners Will Go HigherWhat Is the Price-to-Earnings (P/E) Ratio?Analysts Lift Archer Aviation Stock Despite Earnings Miss DigitalOcean Rides Cloud Wave and AI Hype to Strong EarningsPrice Targets on NVIDIA Rise in Front of Earnings Remove Ads This page (NASDAQ:GMAB) was last updated on 3/24/2025 by MarketBeat.com Staff From Our PartnersTrump Makes Major Crypto AnnouncementTrump Ends the “War on Crypto” I expect it to pump the market, which is why I'm recommending ONE coin to al...Crypto 101 Media | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredMost gold “analysts” aren’t really gold analysts… [watch out]People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Genmab A/S Please log in to your account or sign up in order to add this asset to your watchlist. Share Genmab A/S With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy GMAB Stock Free GMAB Stock Alerts